Bausch Health Companies (TSE:BHC) Stock Price Down 8.7% – Here’s What Happened

Bausch Health Companies Inc. (TSE:BHC) fell 8.7% during mid-day trading on Wednesday . The company traded as low as C$10.67 and last traded at C$10.77. 62,824 shares traded hands during trading, a decline of 83% from the average session volume of 365,759 shares. The stock had previously closed at C$11.80.

Wall Street Analyst Weigh In

Separately, Evercore ISI raised shares of Bausch Health Companies to a “hold” rating in a report on Tuesday, October 15th.

Bausch Health Companies Price Performance

The company has a debt-to-equity ratio of 7,583.76, a current ratio of 1.19 and a quick ratio of 0.58. The firm has a market capitalization of C$3.91 billion, a P/E ratio of -6.15, a P/E/G ratio of 0.21 and a beta of 0.77. The firm’s 50 day simple moving average is C$11.71 and its two-hundred day simple moving average is C$9.88.

Bausch Health Companies (TSE:BHC) last posted its quarterly earnings results on Wednesday, October 30th. The company reported C$1.53 earnings per share for the quarter, topping the consensus estimate of C$1.43 by C$0.10. The business had revenue of C$3.42 billion during the quarter, compared to the consensus estimate of C$3.36 billion. Bausch Health Companies had a negative net margin of 5.12% and a negative return on equity of 2,304.54%. As a group, analysts predict that Bausch Health Companies Inc. will post 5.5472637 earnings per share for the current year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.